Arkolith/Insider Trading/TBIO/Form 4

Witney Frank

DirectorTelesis Bio Inc. (TBIO) · full profile →Form 4 · filed May 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2024Grant(A)48K—$0116K
Jul 6, 2023Grant(A)47K—$067K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2024Grant(A)30K—$030K
Jul 6, 2023Grant(A)70K—$070K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-053136) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML